Ian R. Holzman
- PROFESSOR Pediatrics, Newborn Medicine
- PROFESSOR Obstetrics, Gynecology and Reproductive Science
Print Profile
Specialty
Certifications
Neonatal & Perinatal Medicine
American Board of Pediatrics
Clinical Focus
- Anoxic Brain Damage
- Intubation And Mechanical Ventilation
- Necrotizing Enterocolitis
- Neonatal Sepsis
- Patent Ductus Arteriosus
- Persistent Pulmonary Hypertension
- Premature Birth
- Respiratory Distress Syndrome
- Small Bowel Obstruction
Education
MD, University of Pittsburgh
Residency, Pediatrics
Children's Hospital of PittsburghResidency, Pediatrics
Children's Hospital of PittsburghFellowship, Perinatal Medicine
University of Colorado
Biography
Dr. Ian Holzman received his medical degree from the University of Pittsburgh and he completed his pediatric training at the Children’s Hospital of Pittsburgh. He did a fellowship in neonatology at the University of Colorado and then was on the neonatal faculty at the University of Pittsburgh prior to coming to Mount Sinai to become the Chief of Newborn Medicine and Professor of Pediatrics, Obstetrics, Gynecology and Reproductive Sciences. He presently serves as the Vice Chair for Clinical Affairs in the Department of Pediatrics. Among other responsibilities, Dr. Holzman is the President of the Independent Physicians Organization, the Chair of the Ethics Committee and the Laboratory Committee, and a member of the Board of Governors of the faculty Practice Association and the Children’s Center Foundation. He also serves on the Hospital Professionalism Committee, the Credentials Committee, the Appointments and Promotions Committee and various Quality Assurance Committees.
Awards
2009 -
Best Doctors
New York Magazine
Research
New topic
Dr. Holzman’s research interests include understanding the etiology of necrotizing enterocolitis, examining treatment strategies for breathing problems in newborns and nutritional practices in the neonatal intensive care unit. He also works in the area of bioethics with a special interest in problems related to newborns and in surrogate decision-making.
Publications
Hempel B, Holzman IR. End of life decision making regarding infants of artificial reproductive techniques and spontaneous conception. Journal of Neonatal-Perinatal Medicine 2008; 1: 31-35.
Schulman J, Stricof RI, Stevens TP, Holzman IR. Development of a statewide collaborative to decrease NICU central line associated bloodstream infections. Journal of Perinatology 2009; 29: 591-599.
Peng L, Li ZR, Green RS, Holzman IR, Lin J. Butyrate enhances the intensital barrier by facilitating tight junction assembly via activation of AMP activated protein kinase in Cao-2 cell monolayers. Journal of Nutrition 2009; 139: 1619-25.
Holzman IR. Policy statement (American Academy of Pediatrics):Pediatrician-family-patient relationships: Managing the boundaries. Pediatrics 2009; 124: 1685-1688.
Holzman IR. Committee on Bioethics, Policy Statement. Contributing author. Physician refusal to provide information or treatment on the basis of claims of conscience. Pediatrics 2009; 124: 1689-1693.
Hyman SJ, Novoa Y, Holzman IR. Perinatal endocrinology: Common endocrine disorders in the sick and premature infant. Endocrinology and Metabolism Clinics of North America 2009; 38: 509-524.
Holzman IR. Commentary: calibrating the moral compass. Cambridge Quarterly of Healthcare Ethics 2010; 19: 411-413.
Gibbs KA, Kleinman LC, Jenkins SG, Herold BC, Holzman IR. The vulnerable very low birth weight infant: Late onset bloodstream infections. Journal of Neonatal-Perinatal Medicine 2010; 3: 117-125.
Howell EA, Holzman IR. Surfactant use for premature infants with respiratory distress syndrome in three New York City hospitals: discordance of practice from a community consensus standard. Journal of Perinatology 2010; 30: 590-595.
Schulman J, Stricoff R, Stevens T, Horgan M, Gase K, Holzman IR. Statewide decline in NICU central line associated bloodstream infection rates after implementing bundles and checklists. Pediatrics 2010; 127: 436-444.
Holzman IR. Clincal Ethics in Pediatrics: A Case-Based Textbook 2011. Cambridge University Press;.
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Holzman did not report having any of the following types of financial relationships with industry during 2012 and/or 2013: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
1176 Fifth Avenue
3rd Floor
New York, NY 10029
- Aetna U.S. Healthcare
- CHAMPUS (Tri-care)
- CHUBB Health
- CIGNA - Indemnity
- Healthfirst
- Medicaid
- Medicare Assignment
- Other
- Oxford Health Plans
- Physicians Health Services
- Prem Preferred Care/Beechstreet
- Private Healthcare Systems (PHCS)
- Prudential Healthcare: a member company of Aetna
- United Healthcare
- Master Card
- Visa
- American Express
- Discover
- Personal Check
- Cash